logo
episode-header-image
Sep 25
29m 41s

Urinary Tract Malignancies

NINJA NERD
About this episode
Ninja Nerds! In this episode of the Ninja Nerd Podcast, Zach and Rob dive into the essential clinical and pathophysiologic features of urinary tract malignancies, beginning with renal cell carcinoma (RCC) and followed by urothelial carcinoma of the bladder. We start with a patient case of renal cell carcinoma, exploring the epidemiology and risk factors suc ... Show More
Up next
Nov 20
Gynecological Cancers
<p>Ninja Nerds!</p><p><br/>In this episode of the Ninja Nerd Podcast, Zach and Rob guide you through diagnosing, staging, and management of gynecological cancers using five high-yield, case-based discussions.<br/><br/>We start with a 58-year-old postmenopausal woman presenting wi ... Show More
43m 37s
Nov 6
Pancreatic and Hepatobiliary Cancer
<p>Ninja Nerds!<br/>In this episode of the Ninja Nerd Podcast, Zach and Rob explore pancreatic and hepatobiliary cancers through four patient cases packed with clinical pearls.<br/><br/>We begin with a 63-year-old man presenting with painless jaundice, pruritus, and weight loss. ... Show More
36m 59s
Oct 23
Esophageal & Gastric Cancer
<p>Ninja Nerds!</p><p><br/>In this episode of the Ninja Nerd Podcast, Zach and Rob discuss two high-yield, board-relevant cases highlighting the diagnosis, staging, and treatment of esophageal adenocarcinoma and intestinal-type gastric adenocarcinoma.<br/><br/>We begin with a 56- ... Show More
28m 56s
Recommended Episodes
Jul 2024
Ep. 178 ASCO 2024: Game-Changing GU Oncology Updates in Bladder and Kidney Cancers with Dr. Sumanta Pal and Dr. Petros Grivas
Stay up-to-date on the latest advancements and treatment strategies in the field of genitourinary oncology. In this episode of BackTable Urology, guest host Dr. Bogdana Schmidt, a urologic oncologist from the University of Utah, discusses takeaways from ASCO 2024 with Dr. Petros ... Show More
56m 23s
Feb 2025
AUA Guidelines: Treatment Of Non - Metastatic Muscle - Invasive Bladder Cancer
AUA Guidelines: Treatment Of Non - Metastatic Muscle - Invasive Bladder Cancer Guest: Jeffrey M Holzbeierlein, MD Outline: Segment #1: Guideline Statement 9-Patients who have not received cisplatin-based NAC and have pT3-4 and/or N= disease at cystectomy should receive adjuvant c ... Show More
35m 22s
Jan 2025
Biomarkers and Molecular Imaging for Prostate Cancer (Republished)
Biomarkers and Molecular Imaging for Prostate Cancer CME Available: auau.auanet.org/node/41727 ACKNOWLEDGEMENTS: Support provided by independent educational grants from: Lantheus Medical Imaging Novartis Pharmaceuticals Corporation LEARNING OBJECTIVES: At the conclusion of this a ... Show More
33m 29s
Mar 2024
Ep. 422 Pathology 101: Solid Advice for Percutaneous Biopsies with Dr. Andrew Sholl
In this episode of the BackTable Podcast, host Dr. Chris Beck interviews guest Dr. Andrew Sholl, who demystifies the ins and outs of percutaneous biopsies and their impact on diagnoses. Dr. Scholl is a pathologist at LCMC Health in New Orleans, Louisiana. Dr. Sholl emphasizes th ... Show More
55m 5s
Jun 2025
Ep. 553 Dosimetry University Part II: Understanding Partition and Voxel-Based Approaches with Dr. Tyler Sandow and Dr. Nima Kokabi
BSA, MIRD, or voxel-based dosimetry? Join us for part 2 of Dosimetry University where interventional oncologists Dr. Tyler Sandow, Dr. Nima Kokabi, and Dr. Kavi Krishnasamy explore and debate the critical nuances of a successful Y90 procedure, covering dosing methods, lung shunt ... Show More
1h 1m
Aug 2024
Renal Cell Carcinoma
<p>Renal cell carcinoma has an estimated lifetime prevalence of 2.3% for men and 1.3% for women in the US. Affected patients in early stages can have >94% cancer-specific survival. Author William Y. Kim, MD, of the University of North Carolina joins JAMA Associate Editor David L. ... Show More
21m 14s
Sep 24
Episode 65. Circulating Tumor DNA in DLBCL with Dr. Ash Alizadeh and Dr. David Russler-Germain
In this episode of Blood Cancer Talks, hosts Eddie, Ashwin, and Raj welcome two distinguished experts to explore the cutting-edge field of circulating tumor DNA (ctDNA) in B-cell lymphomas. Dr. David Russler-Germain, a lymphoma clinician from Siteman Cancer Centre at Washington U ... Show More
53m 8s
Aug 2024
AUA2024:How to use PSMA-PET/CT in the Management of Relapsing Prostate Cancer Patients
How to use Prostate-Specific Membrane Antigen-Positron Emission Tomography/CT in the Management of Relapsing Prostate Cancer Patients following Local Therapy with Curative Intent CME Available: https://auau.auanet.org/node/41124 At the conclusion of this activity, participants wi ... Show More
1h 41m
May 2023
AUANewsWorthy Webinar: An Integrated Biomarker and MRI Risk Assessment Approach to Prostate Cancer Diagnosis
Prostate cancer diagnostic guidelines aim to minimize over-diagnosis of clinically insignificant prostate cancer (Gleason6/GG1). The clinical question before us is how do we enable the best balance, helping to increase compliance with the biopsy recommendation for patients at hig ... Show More
51m 37s
Jul 2018
AUA2018 058IC - Management of Common Dilemmas in Prostate Cancer Diagnosis, Staging and Treatment
We will discuss common PSA dilemmas: 1. Who should be screened? 2. What is the role of MRI in biopsy naive and men with prior negative biopsy? 3. What other markers can be used to determine whether biopsy or rebiopsy is warranted? 4. Whats the optimal biopsy strategy: Transrectal ... Show More
2h 1m